Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-16-137724
Filing Date
2016-12-02
Accepted
2016-12-02 16:31:02
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM S-3 v454329_s3.htm S-3 166870
2 EXHIBIT 5 v454329_ex5.htm EX-5 8845
3 EXHIBIT 23.1 v454329_ex23-1.htm EX-23.1 2484
4 GRAPHIC logo_ex5.jpg GRAPHIC 13936
  Complete submission text file 0001144204-16-137724.txt   198622
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-214889 | Film No.: 162031522
SIC: 2836 Biological Products, (No Diagnostic Substances)